Amarin Corp Plcuk (AMRN) Research & Development (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Research & Development of $1.5 million for Q1 2026, down 25.51% YoY from $2.0 million in Q1 2025, and down 71.68% sequentially from $5.4 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Research & Development (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Research & Development across 17 years of filings, most recently posting $1.5 million for Q1 2026.

  • In Q1 2026, Research & Development fell 25.51% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $13.1 million (up 715.95% YoY), while the FY2025 annual figure was $19.8 million, up 139.32% from the prior year.
  • Research & Development retreated to $1.5 million in Q1 2026, from $5.4 million in the prior quarter.
  • Over the last five years, Research & Development for AMRN reached as high as $10.1 million in Q1 2022 and fell as low as -$7.4 million in Q4 2022.
  • The 5-year median for Research & Development is $4.9 million (2025), against an average of $2.8 million.
  • Annual changes were most pronounced in 2022 — Research & Development tumbled 228.73% — and 2025, when it surged 181.28%.
  • A 5-year view of Research & Development shows it stood at -$7.4 million in 2022, then rose by 3.35% to -$7.2 million in 2023, then advanced by 7.68% to -$6.6 million in 2024, then soared by 181.28% to $5.4 million in 2025, then tumbled by 71.68% to $1.5 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $1.5 million, $5.4 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 3.51 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 3.53 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 2.47 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -3.49 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 12.59 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.72 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 1.37 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.49 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 1.52 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.52 Mn
Dec 31, 2025 5.37 Mn
Sep 30, 2025 1.29 Mn
Jun 30, 2025 4.92 Mn
Mar 31, 2025 2.04 Mn
Dec 31, 2024 -6.61 Mn
Sep 30, 2024 1.43 Mn
Jun 30, 2024 4.75 Mn
Mar 31, 2024 5.60 Mn
Dec 31, 2023 -7.16 Mn
Sep 30, 2023 5.11 Mn
Jun 30, 2023 5.64 Mn
Mar 31, 2023 5.68 Mn
Dec 31, 2022 -7.41 Mn
Sep 30, 2022 5.77 Mn
Jun 30, 2022 9.36 Mn
Mar 31, 2022 10.05 Mn
Dec 31, 2021 5.75 Mn
Sep 30, 2021 7.82 Mn
Jun 30, 2021 6.36 Mn